AbbVie (ABBV) Long-Term Debt Issuances (2015 - 2026)

AbbVie (ABBV) has 8 years of Long-Term Debt Issuances data on file, last reported at $8.0 billion in Q1 2026.

• Long-Term Debt Issuances for Q1 2026 came in at $8.0 billion, up 100.08% year-over-year; the trailing twelve-month figure through Mar 2026 was $8.0 billion (up 33.32% YoY), and the FY2025 annual result was $4.0 billion, down 76.45% from the prior year.
• Long-Term Debt Issuances improved to $8.0 billion in Q1 2026 per ABBV's latest filing, from $4.0 billion in the prior quarter.
• Over five years, Long-Term Debt Issuances peaked at $15.0 billion in Q1 2024 and troughed at $2.0 billion in Q1 2022.
• A 4-year average of $6.2 billion and a median of $4.0 billion in 2025 frame the typical range for Long-Term Debt Issuances.
• The sharpest annual moves came in 2025 and 2026: Long-Term Debt Issuances sank 73.31% in 2025, then soared 100.08% in 2026.
• A 4-year view of Long-Term Debt Issuances shows it stood at $2.0 billion in 2022, then changed by 0.0% to $2.0 billion in 2024, then soared by 99.7% to $4.0 billion in 2025, then soared by 100.08% to $8.0 billion in 2026.
• Business Quant data shows ABBV's Long-Term Debt Issuances at $8.0 billion in Q1 2026, $4.0 billion in Q1 2025, and $2.0 billion in Q4 2024.